The spectrum of podocytopathies: a unifying view of glomerular diseases. (Q36780741)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410103%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

review article

1 reference

title

The spectrum of podocytopathies: a unifying view of glomerular diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410103%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410103%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Wiggins RC

1 reference

16 August 2017

language of work or name

English

0 references

publication date

4 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410103%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410103%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410103%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410103%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

1205-1214

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17410103%20AND%20SRC:MED&resulttype=core&format=json

The hyperfiltration theory: a paradigm shift in nephrology

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

The cellular basis of kidney development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Podocyte biology and response to injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Cell biology of the glomerular podocyte

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

The role of podocytes in glomerular pathobiology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

A podocentric view of nephrology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

The slit diaphragm: a signaling platform to regulate podocyte function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Alport's syndrome, Goodpasture's syndrome, and type IV collagen.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

WT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Variants in the Wilms' tumor gene are associated with focal segmental glomerulosclerosis in the African American population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Podocyte is the major culprit accounting for the progression of chronic renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Stem cells and kidney injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Bone-marrow-derived stem cells repair basement membrane collagen defects and reverse genetic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Glomerular basement membrane length to podocyte ratio in human nephronopenia: implications for focal segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Podocyte lesions in patients with obesity-related glomerulopathy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Podocyte hypertrophy, "adaptation," and "decompensation" associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Evidence for a pathogenic linkage between glomerular hypertrophy and sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Podocyte damage damages podocytes: autonomous vicious cycle that drives local spread of glomerular sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

The major podocyte protein nephrin is transcriptionally activated by the Wilms' tumor suppressor WT1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

WT1 regulates the expression of the major glomerular podocyte membrane protein Podocalyxin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Mutations in the Wilms' tumor 1 gene cause isolated steroid resistant nephrotic syndrome and occur in exons 8 and 9.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Recessive missense mutations in LAMB2 expand the clinical spectrum of LAMB2-associated disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Fyn binds to and phosphorylates the kidney slit diaphragm component Nephrin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Nephrin ectodomain engagement results in Src kinase activation, nephrin phosphorylation, Nck recruitment, and actin polymerization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

CD2AP localizes to the slit diaphragm and binds to nephrin via a novel C-terminal domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Thin basement membrane nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Podocyte phenotypes as defined by expression and distribution of GLEPP1 in the developing glomerulus and in nephrotic glomeruli from MCD, CNF, and FSGS. A dedifferentiation hypothesis for the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Recent approaches to the pathogenesis of minimal-change nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

The urinary podocyte as a marker for the differential diagnosis of idiopathic focal glomerulosclerosis and minimal-change nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Pathologic classification of focal segmental glomerulosclerosis: a working proposal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Focal glomerular sclerosis in nephrotic patients: An electron microscopic study of glomerular podocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Gene Expression Profiles of Podocyte-Associated Molecules as Diagnostic Markers in Acquired Proteinuric Diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Urinary podocytes in primary focal segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Glomerular hypertrophy is associated with hyperinsulinemia and precedes overt diabetes in aging rhesus monkeys

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Low birth weight, nephron number, and kidney disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

The genetic basis of FSGS and steroid-resistant nephrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

TGF-beta concentration specifies differential signaling profiles of growth arrest/differentiation and apoptosis in podocytes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Fabry disease: a morphologic study of 11 cases.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Multiple myeloma, nephrotic syndrome and crystalloid inclusions in podocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Update on HIV-associated nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Modulation of podocyte phenotype in collapsing glomerulopathies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Collapsing glomerulopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Dysregulation of Podocyte Phenotype in Idiopathic Collapsing Glomerulopathy and HIV-Associated Nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Antiretroviral therapy in the treatment of HIV-associated nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Podocytopenia and disease severity in IgA nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Urinary excretion of podocytes reflects disease activity in children with glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Urinary podocytes for the assessment of disease activity in lupus nephritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Urinary excretion of viable podocytes in health and renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Urinary sediment podocalyxin in children with glomerular diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Effects of angiotensin-converting enzyme inhibitor, angiotensin II receptor antagonist and calcium antagonist on urinary podocytes in patients with IgA nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Complement-induced glomerular epithelial cell injury. Role of the membrane attack complex in rat membranous nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Immunoelectron microscopic localization of membrane attack complex and hepatitis B e antigen in membranous nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Podocytes Populate Cellular Crescents in a Murine Model of Inflammatory Glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Loss of the tumor suppressor Vhlh leads to upregulation of Cxcr4 and rapidly progressive glomerulonephritis in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Systemic and glomerular hypertension and progression of chronic renal disease: the dilemma of nephrosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Proteinuria and hypertensive nephrosclerosis in African Americans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Hypertension, glomerular number, and birth weight in African Americans and white subjects in the southeastern United States.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Hypertensive risk factors in kidney disease in African Americans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

ACE inhibition is effective and renoprotective in hypertensive nephrosclerosis: the African American Study of Kidney Disease and Hypertension (AASK) trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

A basis for accelerated progression of diabetic nephropathy in Pima Indians

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Renal redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and diabetic nephropathy: paying homage to the podocyte.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Podocyte loss and progressive glomerular injury in type II diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Glomerular cell number in normal subjects and in type 1 diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Podocyte number in normotensive type 1 diabetic patients with albuminuria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Urinary excretion of podocytes in patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Pioglitazone reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Viable podocytes detach in experimental diabetic nephropathy: potential mechanism underlying glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Podocyte injury underlies the progression of focal segmental glomerulosclerosis in the fa/fa Zucker rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Role of amount and nature of carbohydrates in the course of experimental renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Chronic nephropathy in ad libitum overfed Sprague-Dawley rats and its early attenuation by increasing degrees of dietary (caloric) restriction to control growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Renal disease in obesity: the need for greater attention.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Body mass index and the risk of development of end-stage renal disease in a screened cohort

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Longitudinal studies on the rate of decline in renal function with age.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

The aging kidney: structure, function, mechanisms, and therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Nutritional modulation of ageing: genomic and epigenetic approaches

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021

Mitochondria, oxidants, and aging

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002222

7 January 2021